Experts Rejected for Conflict of Interest and Failure to Use Management Projections

Business Valuation UpdateVol. 8 No. 7
Legal and Court Case Update
July 2002
5122 Drugs, Drug Proprietaries, and Druggists' Sundries
424210 Drugs and Druggists' Sundries Merchant Wholesalers
dissenting shareholder
shareholder dispute

Gray v. Cytokine Pharmasciences, Inc.
2002 Del. Ch. LEXIS 48
April 25, 2002
US
State Court
Delaware
Court of Chancery
Jeffrey B. Davis (for Gray)<br>J. Mark Penny (for Cytokine)<br>Merrill Lynch (for Cytokine)
Lamb

Summary

The issue in this case was the fair value of the shares of PharmaSciences Inc. (PSI).

See Also

Gray v. Cytokine Pharmasciences, Inc.

The issue in this case was the fair value of the shares of PharmaSciences, Inc.